Research.Patient.info

Aicardi-Goutières Syndrome (AGS) research hub

1 indexed studies · 0 currently recruiting

ongoing, recruitingTherapeutic exploratory (Phase II)
A Phase 2a Study of TPN-101 in Patients with Aicardi-Goutières Syndrome (AGS)
Researchers are testing a new medicine called censavudine for Aicardi-Goutières Syndrome (AGS). They want to see if it can reduce inflammation and improve health in patients aged 18 and over. This is an early-stage study to check safety and how the medicine works.
France · Italy